Table 3.
Follow-up results and complications by cannulation sites.
| Variable | Group A | Group B | Group C | Group D | P-value |
|---|---|---|---|---|---|
| (N: 80) | (N: 31) | (N: 94) | (N: 5) | ||
| N (%) | N (%) | N (%) | N (%) | ||
| Bleeding | 40 (50.0) | 12 (38.7) | 38 (40.4) | 1 (20.0) | 0.37 |
| Dialysis | 8 (10.0) | 15 (48.4)f | 18 (19.1) | 0 | < 0.001* |
| Cerebrovascular event | 13 (16.2) | 10 (32.3) | 20 (21.3) | 2 (40.0) | 0.22 |
| Peripheral ischemia | 7 (8.8) | 6 (19.4) | 15 (16.0) | 0 | 0.29 |
| Pneumonia | 9 (11.2) | 2 (6.5) | 22 (23.4)f | 0 | 0.03* |
*
Statistically significant parameter
f
Group that makes statistically significant difference
Group A: Central cannulation
Group B: Femoral venous-axillary arterial cannulation
Group C: Femoral venous-femoral arterial cannulation
Group D: Jugular venous-femoral arterial cannulation